Cocrystal Pharma (COCP) Change in Cash (2010 - 2026)

Cocrystal Pharma (COCP) has 17 years of Change in Cash data on file, last reported at -$2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 20.38% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$2.2 million (up 85.01% YoY), and the FY2025 full-year result was -$2.8 million, up 82.81% from the prior year.
• Change in Cash eased to -$2.3 million in Q1 2026, from -$704000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.0 million in Q3 2025 to a low of -$9.0 million in Q3 2022.
• A 5-year average of -$3.2 million and a median of -$3.2 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash tumbled 1561.19% in 2022 and surged 157.84% in 2025, its largest moves.
• Tracing COCP's Change in Cash over 5 years: stood at -$4.9 million in 2022, then jumped by 31.09% to -$3.4 million in 2023, then rose by 6.65% to -$3.2 million in 2024, then surged by 77.72% to -$704000.0 in 2025, then sank by 232.39% to -$2.3 million in 2026.
• Business Quant data shows COCP's Change in Cash at -$2.3 million in Q1 2026, -$704000.0 in Q4 2025, and $3.0 million in Q3 2025.